Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Sold under brand names including Wegovy and Ozempic ... reduced weekly alcohol cravings compared with those on placebo. “We didn’t have any evidence of significant adverse effects or safety ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

An "exciting" new study has found that Semaglutide, the active ingredient of Wegovy and Ozempic, could help people to reduce their alcohol intake. The drugs were originally developed to treat type ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current best-selling drug in this area, Wegovy ... $1,000 when we doubled down ...

"Wegovy, Ozempic, they all have the same active ... largely done by people who will stay here," said Brooks-Lasure. "We have got to get a handle on prescription drug costs in this country, and ...

So we're quite confident both in the demand in the market and also our ability to supply and compete in that market." People taking Wegovy start off on the lowest dose – or the starter dose ...

Novo Nordisk's U.S.-listed shares rose 5% in intraday trading after the Ozempic and Wegovy maker's better-than-estimated ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs. Net profit for the fourth ...

In addition to Wegovy, incretin mimetics FDA-approved for ... teased upcoming bipartisan legislation relevant to the ad. “We recognize the important roles that pharmaceutical compounding and ...